Rejoice, fellow vaccine lovers—it appears to be like like there’s excellent news on the horizon for Novavax, everybody’s favourite scrappy, extremely efficient, Matrix-M adjuvanted, protein-based, non-mRNA COVID-19 vaccine, which additionally has the fewest unwanted effects, besides. The corporate introduced yesterday that, after some delays that spurred sufferers and shoppers to double down on their advocacy efforts, the COVID-19 Novavax vaccine appears to be like to be on monitor to maneuver from emergency authorization to full approval from the Meals and Drug Administration—which implies Novavax will be capable to present the vaccine indefinitely. — Learn the remainder
The put up After delays, Novavax Covid vaccine is on monitor for full FDA approval appeared first on Boing Boing.
